Journal of Bone and Joint Infection
Journal of Bone and Joint Infection
JBJI
Articles | Volume 10, issue 4
Articles | Volume 10, issue 4
https://doi.org/10.5194/jbji-10-255-2025
© Author(s) 2025. This work is distributed under
the Creative Commons Attribution 4.0 License.
https://doi.org/10.5194/jbji-10-255-2025
© Author(s) 2025. This work is distributed under
the Creative Commons Attribution 4.0 License.
Articles | Volume 10, issue 4
Original full-length article
 | 
30 Jul 2025
Original full-length article |  | 30 Jul 2025

Proactive Therapeutic Drug MONiToring to Guide Suppressive Antibiotic Therapy with DALBAvaNcin ( > 12 weeks) in Osteoarticular Infections (MONTALBANO)

Chiara Mariani, Matteo Passerini, Lucia Galli, Alice Covizzi, Marta Colaneri, Martina Offer, Margherita Faenzi, Stefania Merli, Simona Landonio, Marta Fusi, Alberto Dolci, Andrea Gori, and Dario Cattaneo

Viewed

Total article views: 26 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
23 2 1 26 0 0
  • HTML: 23
  • PDF: 2
  • XML: 1
  • Total: 26
  • BibTeX: 0
  • EndNote: 0
Views and downloads (calculated since 30 Jul 2025)
Cumulative views and downloads (calculated since 30 Jul 2025)

Viewed (geographical distribution)

Total article views: 26 (including HTML, PDF, and XML) Thereof 26 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 01 Aug 2025
Download
Short summary
Bone and joint infections often require prolonged antibiotic treatments over 12 weeks. Dalbavancin, an intravenous antibiotic given at spaced intervals, offers a promising option. Our study developed a method to optimize dosing schedules using two blood tests to measure drug levels. This ensures effective treatment while avoiding excessive accumulation. These findings suggest dalbavancin is a safe, effective choice for managing long-term infections.
Read more
Share